Literature DB >> 31942554

Ventricular fibrillation associated with Graves' disease and amiodarone induced thyrotoxicosis.

Jake Cho1,2, Bosede Afolabi3,4.   

Abstract

This case involves a 55-year-old male patient with systolic heart failure and refractory atrial fibrillation due to thyrotoxicosis, who was electrically cardioverted but then developed torsade de pointes and ventricular fibrillation. Rate control was unsuccessful with digoxin, cardizem, labetalol, esmolol and amiodorone. Patient was externally cardioverted after which ECGs showed prolonged QT with frequent premature ventricular contractions. ECGs also showed 'R-on-T' phenomenon leading to torsades and ventricular fibrillation. Atrial overdrive pacing was used to terminate the dangerous arrhythmia and the patient returned to sinus rhythm. Interestingly, he was found to have new onset thyrotoxicosis and started on methimazole.
Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Keywords:  R-on-T phenomenon; amiodarone; electrophysiology; thyrotoxicosis; torsade de pointes; ventricular fibrillation

Year:  2019        PMID: 31942554      PMCID: PMC6946153          DOI: 10.1097/XCE.0000000000000184

Source DB:  PubMed          Journal:  Cardiovasc Endocrinol Metab        ISSN: 2574-0954


  13 in total

Review 1.  Cardiac resynchronization therapy (CRT): clinical trials, guidelines, and target populations.

Authors:  Cecilia Linde; Kenneth Ellenbogen; Finlay A McAlister
Journal:  Heart Rhythm       Date:  2012-04-20       Impact factor: 6.343

2.  Cardiac arrest due to torsades de pointes in a patient with complete heart block: the "R-on-T" phenomenon.

Authors:  Albert P Nguyen; Syed A Sarmast; Robert C Kowal; Jeffrey M Schussler
Journal:  Proc (Bayl Univ Med Cent)       Date:  2010-10

Review 3.  Adult heart transplant: indications and outcomes.

Authors:  M Chadi Alraies; Peter Eckman
Journal:  J Thorac Dis       Date:  2014-08       Impact factor: 2.895

Review 4.  Cardiac hypertrophy: a risk factor for QT-prolongation and cardiac sudden death.

Authors:  Y James Kang
Journal:  Toxicol Pathol       Date:  2006       Impact factor: 1.902

Review 5.  Long QT syndromes and torsade de pointes.

Authors:  S Viskin
Journal:  Lancet       Date:  1999-11-06       Impact factor: 79.321

Review 6.  Management of Ventricular Arrhythmias in Patients With Advanced Heart Failure.

Authors:  Pasquale Santangeli; J Eduardo Rame; Edo Y Birati; Francis E Marchlinski
Journal:  J Am Coll Cardiol       Date:  2017-04-11       Impact factor: 24.094

7.  Amiodarone-induced thyrotoxicosis: clinical course and predictors of outcome.

Authors:  David Conen; Ludovic Melly; Christoph Kaufmann; Stefan Bilz; Peter Ammann; Beat Schaer; Christian Sticherling; Beat Muller; Stefan Osswald
Journal:  J Am Coll Cardiol       Date:  2007-06-04       Impact factor: 24.094

Review 8.  Thyroid disease and the heart.

Authors:  Irwin Klein; Sara Danzi
Journal:  Circulation       Date:  2007-10-09       Impact factor: 29.690

9.  Unusual Manifestation of Graves' Disease: Ventricular Fibrillation.

Authors:  Hiroki Kobayashi; Akira Haketa; Masanori Abe; Kazunobu Tahira; Yoshinari Hatanaka; Sho Tanaka; Takahiro Ueno; Masayoshi Soma
Journal:  Eur Thyroid J       Date:  2015-08-26

Review 10.  Abnormalities of Thyroid Hormone Metabolism during Systemic Illness: The Low T3 Syndrome in Different Clinical Settings.

Authors:  Arnaldo Moura Neto; Denise Engelbrecht Zantut-Wittmann
Journal:  Int J Endocrinol       Date:  2016-10-10       Impact factor: 3.257

View more
  1 in total

1.  Thyrotoxicosis in patients with COVID-19: the THYRCOV study.

Authors:  Andrea Lania; Maria Teresa Sandri; Miriam Cellini; Marco Mirani; Elisabetta Lavezzi; Gherardo Mazziotti
Journal:  Eur J Endocrinol       Date:  2020-10       Impact factor: 6.558

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.